VIA EDGAR

 

July 11, 2023

 

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:	Cindy Polynice
	Alan Campbell
	Angela Connell
	Gary Newberry

 

Re:	Sagimet Biosciences Inc. (the “Registrant”)
	Registration Statement on Form S-1 (File No. 333-272901)
	Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 10, 2023 and the date hereof, approximately 1,821 copies of the Preliminary Prospectus, dated July 10, 2023, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.

 

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on July 13, 2023, or as soon thereafter as practicable.

 

[signature page follows]

 

 

	Very truly yours,
	GOLDMAN SACHS & CO. LLC
	COWEN AND COMPANY, LLC
	PIPER SANDLER & CO.
	As representatives of the Underwriters
	GOLDMAN SACHS & CO. LLC
	By:	/s/ Lyla Bibi
		Name: Lyla Bibi
		Title: Managing Director
	COWEN AND COMPANY, LLC
	By:	/s/ Tanya Joseph
		Name: Tanya Joseph
		Title: Managing Director
	PIPER SANDLER & CO.
	By:	/s/ Chad Huber
		Name: Chad Huber
		Title: Managing Director

 

[Signature Page to Acceleration Request Letter]